Colgate-Palmolive vs Ambev

Colgate-Palmolive vs Ambev is a page that compares business models, financial performance, and market context between the two companies. It presents neutral information on how each operates and the environments in which they compete. The aim is to inform readers with clear, accessible language, not to advocate any view. Educational content, not financial advice.

Colgate-Palmolive vs Ambev is a page that compares business models, financial performance, and market context between the two companies. It presents neutral information on how each operates and the en...

Comparison Snapshot

Key Financial Metrics

CL

Metric

ABEV

$68.68B

Market Cap

$44.92B

2.50%

Potential Profit

N/A

Buy

Analyst Rating

N/A

Why It's Moving

Colgate-Palmolive Draws Mixed Analyst Views Ahead of Pivotal Q4 Earnings

JPMorgan hiked its target to $93 with an Overweight rating, betting on plain-vanilla stability despite mixed U.S. consumer signals in the sector preview.
TD Cowen cut to $86 but held Buy, warning of a tough 2026 with weak volume growth echoing last year's -0.9% dip.
Ex-dividend action hit January 21, delivering $0.52 per share to holders, underscoring CL's appeal as a dividend stalwart in uncertain times.

Sentiment:

⚖️Neutral

Ambev Stock Charges to 1-Year High on Surging Momentum

Shares reached a 52-week peak intraday Wednesday with elevated volume of 4.25 million, underscoring broad market enthusiasm.
Four consecutive days of gains highlight technical strength, with buy signals from short- and long-term moving averages.
Recent special dividend payout bolsters appeal, even as analysts maintain cautious 'Reduce' rating with $2.53 average target.

Sentiment:

🐃Bullish

Colgate-Palmolive Draws Mixed Analyst Views Ahead of Pivotal Q4 Earnings

JPMorgan hiked its target to $93 with an Overweight rating, betting on plain-vanilla stability despite mixed U.S. consumer signals in the sector preview.
TD Cowen cut to $86 but held Buy, warning of a tough 2026 with weak volume growth echoing last year's -0.9% dip.
Ex-dividend action hit January 21, delivering $0.52 per share to holders, underscoring CL's appeal as a dividend stalwart in uncertain times.

Sentiment:

⚖️Neutral

Ambev Stock Charges to 1-Year High on Surging Momentum

Shares reached a 52-week peak intraday Wednesday with elevated volume of 4.25 million, underscoring broad market enthusiasm.
Four consecutive days of gains highlight technical strength, with buy signals from short- and long-term moving averages.
Recent special dividend payout bolsters appeal, even as analysts maintain cautious 'Reduce' rating with $2.53 average target.

Sentiment:

🐃Bullish

Investment Analysis

Colgate-Palmolive

CL

Pros

Colgate-Palmolive reported revenue growth of 3.31% in 2024, reaching $20.10 billion, indicating steady top-line expansion.
The company has strong brand diversification across oral care, personal care, home care, and pet nutrition segments, supporting market resilience.
Colgate-Palmolive maintains a solid dividend yield around 2.7%, offering a consistent income stream for shareholders.

Considerations

Colgate-Palmolive's stock has shown limited price appreciation over the past year, which may be unattractive for growth-focused investors.
The company has a relatively high debt-to-equity ratio, which raises concerns about its financial leverage and risk exposure.
Its price-to-earnings (P/E) ratio near 22 suggests potential overvaluation compared to peers, limiting upside from current levels.

Ambev

ABEV

Pros

Ambev is a leading beverage company in Latin America with strong market share in beer and soft drinks, benefiting from regional brand loyalty and scale.
The company has demonstrated growth potential driven by premium product launches and expansion in emerging markets with rising consumer incomes.
Ambev maintains efficient production and distribution infrastructure, supporting operational margins despite commodity price volatility.

Considerations

Ambev faces currency volatility risks due to significant exposure to emerging markets with fluctuating exchange rates impacting earnings.
The company's performance is sensitive to regulation and taxation changes in the alcoholic beverages sector, which can constrain profitability.
Economic slowdown or reduced consumer spending in key Latin American markets poses demand risks given Ambev's market concentration.

Related Market Insights

Why Familiar Brands Could Be Your Gateway to Stock Market Success

Nervous about investing? Discover how familiar consumer brands like Coca-Cola, PepsiCo & Ambev offer stability, dividends, and an accessible entry point to the stock market. Start with Nemo from £1.

Aimee Silverwood | Financial Analyst

October 13, 2025

Read Insight

Related Market Insights

Why Familiar Brands Could Be Your Gateway to Stock Market Success

Nervous about investing? Discover how familiar consumer brands like Coca-Cola, PepsiCo & Ambev offer stability, dividends, and an accessible entry point to the stock market. Start with Nemo from £1.

Aimee Silverwood | Financial Analyst

October 13, 2025

Read Insight

About The Companies

Colgate-Palmolive (CL)

Colgate‑Palmolive Co. (CL) is a global consumer‑goods company best known for oral‑care brands such as Colgate, alongside personal‑care and household products. With a market capitalisation around US$63.5bn, it generates steady, largely predictable cash flows from everyday consumables sold across retail, pharmacy and e‑commerce channels. Investors often note Colgate’s brand strength, broad distribution network and dividend track record as attractions for income‑orientated portfolios. Growth drivers include premiumisation of oral care, expansion in emerging markets and rising e‑commerce penetration. Key risks are margin pressure from commodity and freight costs, currency volatility in international markets, intense competition from other large consumer goods firms and private labels, and changing consumer preferences. Colgate is generally viewed as a defensive, lower‑volatility stock but like all equities its value can fall as well as rise. This summary is educational only and not personal investment advice — suitability depends on an investor’s goals, risk tolerance and timeframe.

Ambev (ABEV)

Ambev S.A. (ABEV) is a leading brewer and beverage company operating mainly across Latin America. It produces, markets and distributes a wide portfolio of beers and non‑alcoholic beverages, including well‑known regional brands. With a market capitalisation around $35.75 billion, Ambev benefits from scale, an extensive distribution network and strong brand recognition, which can support steady cash generation. Investors should note the company’s exposure to regional consumer spending, commodity costs (like barley and packaging) and currency swings in emerging markets. The business can offer income via dividends and potential long‑term growth through market share gains and operational efficiencies, but returns are not guaranteed. This summary provides general, educational information only and is not personal financial advice; investors should consider their own objectives, risk tolerance and seek professional advice where appropriate.

Colgate-Palmolive (CL) Next Earnings Date

Colgate-Palmolive will report its next earnings on January 30, 2026, which is scheduled for 8:30 a.m. ET. This earnings report will cover the company's fourth quarter and full year 2025 results. Analysts are projecting earnings per share of $0.91 for the quarter, with revenues expected at $5.1 billion, representing a 3.2% year-over-year increase.

Ambev (ABEV) Next Earnings Date

Ambev S.A. (ABEV) has not officially confirmed its next earnings date, with estimates converging around February 12, 2026, though some sources indicate February 25, 2026. This release will cover the fourth quarter of 2025 (Q4 2025) results. Investors should monitor company announcements for the precise timing and conference call details.

Colgate-Palmolive (CL) Next Earnings Date

Colgate-Palmolive will report its next earnings on January 30, 2026, which is scheduled for 8:30 a.m. ET. This earnings report will cover the company's fourth quarter and full year 2025 results. Analysts are projecting earnings per share of $0.91 for the quarter, with revenues expected at $5.1 billion, representing a 3.2% year-over-year increase.

Ambev (ABEV) Next Earnings Date

Ambev S.A. (ABEV) has not officially confirmed its next earnings date, with estimates converging around February 12, 2026, though some sources indicate February 25, 2026. This release will cover the fourth quarter of 2025 (Q4 2025) results. Investors should monitor company announcements for the precise timing and conference call details.

Which Baskets Do They Appear In?

Familiar brands might ease stock market anxiety?

Investing in familiar global brands can make the stock market feel more accessible and understandable for many Brazilians. This basket offers exposure to the US and EU-listed parent companies behind the everyday consumer products found in homes across Brazil.

Published: October 13, 2025

Explore Basket

Which Baskets Do They Appear In?

Familiar brands might ease stock market anxiety?

Investing in familiar global brands can make the stock market feel more accessible and understandable for many Brazilians. This basket offers exposure to the US and EU-listed parent companies behind the everyday consumer products found in homes across Brazil.

Published: October 13, 2025

Explore Basket

Discover More Comparisons

Colgate-Palmolive vs Kroger

Colgate-Palmolive vs Kroger stock comparison

Colgate-Palmolive vs Diageo

Colgate-Palmolive vs Diageo: a quick comparison

Colgate-Palmolive vs Kimberly-Clark

Colgate-Palmolive vs Ambev

Comparison Snapshot

Why It's Moving

Colgate-Palmolive Draws Mixed Analyst Views Ahead of Pivotal Q4 Earnings

Ambev Stock Charges to 1-Year High on Surging Momentum

Colgate-Palmolive Draws Mixed Analyst Views Ahead of Pivotal Q4 Earnings

Ambev Stock Charges to 1-Year High on Surging Momentum